Company: BGLC
Filing Date: 2025-11-07
Form Type: S-3
Source: 0001477932-25-007976
Chunk: 47

Company: BioNexus Gene Lab Corp
Filing Date: 2025-11-07
Form: S-3
Chunk 47
---
 of JP Centurion & Partners PLT, an independent registered public accounting firm, as stated in its report incorporated by reference herein, and have been so incorporated in reliance upon such report and upon the authority of such firm as experts in accounting and auditing.

| S-17 |

<div align='center'>BioNexus Gene Lab Corp.

Up to $3,557,000

Shares of Common Stock

Sole Sales Agent

MAXIM GROUP LLC

The date of this prospectus supplement is _____________.</div>

<div align='center'>PART II

INFORMATION NOT REQUIRED IN THE PROSPECTUS</div>

ITEM 14. OTHER EXPENSES OF ISSUANCE AND DISTRIBUTION

The following table sets forth the estimated costs and expenses, other than underwriting discounts and commissions, payable by us in connection with the offering of the securities being registered. All the amounts shown are estimates, except for the SEC registration fee.

| SEC registration fee              |     | $ | 13,810 |
| FINRA fee                         |     | $ |      * |
| Printing and duplicating expenses |     | $ |      * |
| Legal fees and expenses           |     | $ | 50,000 |
| Accounting fees and expenses      |     | $ |  5,000 |
| Transfer agent fees               |     | $ |      * |
| Miscellaneous expenses            |     | $ |      * |
| Total                             |     | $ |      * |

*These fees and expenses are calculated based on the securities offered and the number of issuances and, accordingly, cannot be estimated at this time. An estimate of the aggregate amount of these expenses will be reflected in the applicable prospectus supplement.

ITEM 15. INDEMNIFICATION OF DIRECTORS AND OFFICERS

Section 78.138 of the Wyoming Revised Statutes (“WRS”) provides that directors and officers of Wyoming corporations may, under certain circumstances, be indemnified against expenses (including attorneys’ fees) and other liabilities actually and reasonably incurred by them as a result of any suit brought against them in their capacity as a director or officer, if they acted in good faith and in a manner they reasonably believed to be in or not opposed to the best interests of the corporation, and, with respect to any criminal action or proceeding, if they had no reasonable cause to believe their conduct was unlawful. WRS also provides that directors and officers may also be indemnified against expenses (including attorneys’ fees) incurred by them in connection with a derivative